Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 16;6(1):9.
doi: 10.3390/diseases6010009.

Rosuvastatin Improves Vaspin Serum Levels in Obese Patients with Acute Coronary Syndrome

Affiliations

Rosuvastatin Improves Vaspin Serum Levels in Obese Patients with Acute Coronary Syndrome

Hayder M Al-Kuraishy et al. Diseases. .

Abstract

Adipose tissue-derived serine protease inhibitor (vaspin), which has endocrine and local roles in atherosclerosis growth, is also synthesized by adipose tissue; it was found that vaspin was negatively correlated with blood pressure in obese patients, while vaspin levels were decreased in endothelial dysfunction. The aim of the present study was to determine rosuvastatin modulation effects on serum vaspin levels in acute coronary syndrome (ACS) with class I obesity. A total number of seventy patients with acute coronary syndrome previously and currently treated with rosuvastatin was compared to 40 patients with IHD not treated by rosuvastatin as a control. Vaspin serum levels were higher in rosuvastatin-treated patients with acute coronary syndrome compared to the patients with acute coronary syndrome not treated by rosuvastatin, p < 0.01. Additionally, in the rosuvastatin-treated group, patients with STEMI showed higher vaspin serum levels compared to NSTEMI p < 0.01.

Conclusion: Rosuvastatin significantly increases vaspin serum levels in acute coronary syndrome.

Keywords: NSTEMI; STEMI; acute coronary syndrome; vaspin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Negative correlation between vaspin serum levels and Hs-CRP in rosuvastatin-treated ACS.
Figure 2
Figure 2
Negative correlation between vaspin serum levels and Hs-CRP in rosuvastatin-free ACS patients.
Figure 3
Figure 3
Sensitivity and specificity of vaspin serum levels in patients with acute coronary syndrome treated with or without rosuvastatin.
Figure 4
Figure 4
Vaspin serum levels in patients with ACS regarding rosuvastatin therapy.

References

    1. Tsaousi G., Pitsis A.A., Ioannidis G.D., Vasilakos D.G. A multidisciplinary approach to unplanned conversion from off-pump to on-pump beating heart coronary artery revascularization in patients with compromised left ventricular function. Crit. Care Res. Pract. 2014;2014:348021. doi: 10.1155/2014/348021. - DOI - PMC - PubMed
    1. Erne P., Radovanovic D., Seifert B., Bertel O., Urban P., AMIS Plus Investigators The outcome of patients admitted with acute coronary syndrome on palliative treatment: Insights from the nationwide AMIS Plus Registry 1997–2014. BMJ Open. 2015;5:e006218. doi: 10.1136/bmjopen-2014-006218. - DOI - PMC - PubMed
    1. Hicks K., Cocks K., Corbacho Martin B., Elton P., MacNab A., Colecliffe W., Furze G. An intervention to reassure patients about test results in rapid access chest pain clinic: A pilot randomised controlled trial. BMC Cardiovasc. Disord. 2014;14:138. doi: 10.1186/1471-2261-14-138. - DOI - PMC - PubMed
    1. Al-Kuraishy H.M., Al-Gareeb A.I., Awad M.S., Alrifai S.B. Assessment of serum prolactin levels in acute myocardial infarction: The role of pharmacotherapy. Indian J. Endocrinol. Metab. 2016;20:72–79. doi: 10.4103/2230-8210.172240. - DOI - PMC - PubMed
    1. Al-Kuraishy H.M., Al-Gareeb A.I. New Insights into the Role of Metformin Effects on Serum Omentin1 Levels in Acute MyocardialInfarction: Cross-Sectional Study. Emerg. Med. Int. 2015;2015:283021. - PMC - PubMed

LinkOut - more resources